Related Experiment Videos
Atypical presentation of subacute sclerosing panencephalitis in 3 patients
Abstract:
Experience with some of our patients suggests that the diagnosis of subacute sclerosing panencephalitis (SSPE) may be made early and confirmed by the demonstration of high levels of measles complement-fixing antibodies in the cerebrospinal fluid (CSF) and serum, in the absence of classic clinical, electroencephalographic or brain biopsy support for the diagnosis. It is not known when the measles-specific antibodies first appear in the CSF, but these 3 atypical cases suggest that they were present in high titre early in the disease.
Insights
Early diagnosis of subacute sclerosing panencephalitis (SSPE) is possible with high measles antibody levels in cerebrospinal fluid (CSF) and serum, even without classic symptoms. These findings suggest antibodies appear early in the disease.
Area of Science:
- Neurology
- Virology
- Immunology
Background:
- Subacute sclerosing panencephalitis (SSPE) is a rare, progressive neurological disorder associated with measles virus infection.
- Diagnosis typically relies on clinical presentation, electroencephalography (EEG), and brain biopsy, often confirmed by elevated measles antibodies.
- The early diagnostic window for SSPE remains unclear.
Observation:
- Three atypical cases of SSPE were identified.
- These patients presented with high levels of measles complement-fixing antibodies in both cerebrospinal fluid (CSF) and serum.
- Crucially, these antibody levels were detected in the absence of definitive clinical, EEG, or brain biopsy evidence.
Findings:
- The study suggests that elevated measles-specific antibodies in CSF and serum can be an early indicator of SSPE.
- High antibody titers may be present even before the classic diagnostic criteria are met.
- This indicates a potential for earlier diagnosis than previously recognized.
Implications:
- Early detection of SSPE through serological markers could lead to timely intervention and management.
- This diagnostic approach may be particularly valuable in atypical presentations of the disease.
- Further research is warranted to establish the precise timing of antibody appearance in CSF during SSPE progression.